India ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis

India ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis


$ 3999

India's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is expected to grow from $538 Mn in 2022 to $1,195 Mn in 2030 with a CAGR of 10.5% for the year 2022-30. With a larger prevalence of ADHD in India than that globally, the ADHD therapeutics market in India has a lot of potential. The India ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Actiza Pharmaceutical, Ayursun Pharma, and Eli Lily are some of the key players in the market.

ID: IN10INPH028 CATEGORY: Pharmaceuticals GEOGRAPHY: India AUTHOR: Parul Choudhary

Buy Now

India Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Executive Analysis

The India Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market size is at around $538 Mn in 2022 and is projected to reach $1,195 Mn in 2030, exhibiting a CAGR of 10.5% during the forecast period. The Ministry of Health and Family Welfare received $10.79 Bn from the Union Budget 2023-24, a rise of almost 3.4% from $10.43 Bn in FY 2022-23. Amounting to 21% less than the $4.48 Bn allotted in 2022-23, the National Health Mission (NHM) received $3.52 Bn. This was mainly brought on by the Pradhan Mantri Swasthya Suraksha Yojana's (PMSSY) significant 66.4 % decrease in funding from $1.21 Bn in the previous budget to $0.40 Bn this year. However, as part of other Central Sector Expenditures, a sum of $0.82 Bn has been reallocated for the setup costs of 22 new AIIMS.

One of the most common neurological developmental disorders affecting children, teenagers, and even adults is attention-deficit hyperactivity disorder (ADHD). It shows up as concentration problems, hyperactivity, and impulsivity. Impulsivity and ADHD can interfere with a student's ability to compete in sports, achieve objectives, and do well in academic settings. Numerous observational studies have been conducted over the past ten years to gauge the prevalence of ADHD in children in India. However, the prevalence reported in a number of studies is restricted to a particular geographic area, and the prevalence is also found to vary widely between studies. For example, the prevalence in individuals aged between 6 and 18 years in Kashmir was 4.31%, whereas, in individuals aged between 6 and 12 years in Bangalore, it was 2.3%, in individuals aged between 6 and 18 years in Odisha was 3.66%, in individuals aged between 10 and 16 years in New Delhi was 6.4%, in individuals aged between 6 and 11 years in Assam was 12.66%. Recognizing the prevalence of ADHD in kids and teenagers will aid clinicians in making an early evaluation, which will lessen the negative effects of this syndrome.

Treatments for ADHD symptoms aim to improve symptoms by balancing and enhancing hormones. About 70-80% of individuals who take stimulant medications report success. They can be applied to both mild and serious ADHD symptoms.

 For children older than 3 and older than 6, respectively, certain stimulants are permitted. Children, teenagers, and adults who struggle at work, home, or school can benefit from these medications. Stimulants can help concentrate better and block out distractions. Amphetamine, also known as Adderall, Adzenys, and Dextroamphetamine, also known as Dexedrine, are a few examples of stimulants. Non-stimulants can help to reduce side effects when the side effects from the stimulants are severe. Here are a few instances of non-stimulants: Atomoxetine or bupropion is the first non-stimulant medication that the FDA has authorized for use in treating ADHD in children, adolescents, and adults. The drug clonidine hydrochloride (Kapvay) has also received approval. It may be recommended for use both alone and with another stimulant. Guanfacine (Intuniv) is a medication that can be used by kids and teenagers between the ages of 6 and 17.

Although there is a significant amount of ADHD prevalence in India, parents are still reluctant to give their kids ADHD medications. According to a study titled a preliminary study of factors influencing adherence to medication in clinic children with attention-deficit/hyperactivity disorder, 83.3% of those who are given ADHD medications stop taking them within the first month.

india attention deficit hyperactivity disorder market analysis

Market Dynamics

Market Growth Drivers

The market for ADHD therapeutics in India has an enormous amount of potential given that the prevalence of ADHD is much higher than the global average. There is a rising need for improved healthcare facilities and services in India as people's disposable income rises. This is anticipated to result in a rise in the use of ADHD therapeutics, which will fuel the market's expansion. In order to increase access to healthcare services, the Indian government has actively supported the healthcare industry and enacted a number of programs. This is anticipated to fuel the India ADHD therapeutics market's expansion.

Market Restraints

Parents of ADHD patients are reluctant to continue their child's therapy due to side effects, ineffectiveness, hospital issues, and concerns about the child developing an addiction, which is limiting the India ADHD therapeutics market's expansion.

Although there has been a rise in awareness of ADHD in India, the condition is still not well understood. The lack of awareness of ADHD symptoms among many parents, caregivers, and medical workers can delay diagnosis and treatment. In India, contempt related to mental health, including ADHD, is still very strong. This may discourage people with ADHD from getting care or from speaking up about their condition, which may restrain the India ADHD therapeutics market's expansion.

Competitive Landscape

Key Players

  • Chiral Drugs (IND)
  • CTX Lifesciences (IND)
  • KLM Laboratories (IND)
  • Actiza Pharmaceutical (IND)
  • Ayursun Pharma (IND)
  • Eli Lily
  • Pfizer
  • Johnson & Johnson
  • Lupin
  • Shire
  • Mallinckrodt
  • Prude Pharma
  • NEOS Therapeutics

Healthcare Policies and Regulatory Landscape

The National Regulatory Authority (NRA) of India is the Central Drugs Standard Control Organization (CDSCO) under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India. The Drugs & Cosmetics Act, 1940 and the rules of 1945 have given central and state regulators different duties for the control of drugs & cosmetics. It plans on implementing the Act and its Rules sections consistently in order to protect patients' safety, rights, and well-being by controlling the use of drugs and cosmetics. In order to guarantee the safety, effectiveness, and quality of the medical products produced, imported, and disseminated in the nation, CDSCO is constantly working to increase transparency, accountability, and uniformity in its services.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Segmentation

By Drug Type (Revenue, USD Billion):

  • Stimulants
    • Amphetamine
    • Methylphenidate
    • Dextroamphetamine
    • Dexmethylphenidate
    • Lisdexamfetamine
    • Others
       
  • Non-Stimulants
    • Atomoxetine
    • Bupropion
    • Guanfacine
    • Clonidine

By Age Group (Revenue, USD Billion):

  • Pediatric And Adolescent
  • Adult

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Speciality Clinics
  • Retail Pharmacies
  • e-Commerce

By Psychotherapy (Revenue, USD Billion):

  • Behaviour Therapy
  • Cognitive Behavioral Therapy
  • Interpersonal Psychotherapy
  • Family Therapy

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 23 March 2023
Updated by: Dhruv Joshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up